| 瑞典专利药价格管理政策的经验启示 |
| |
| 引用本文： | 武瑞雪,叶露.瑞典专利药价格管理政策的经验启示[J].中国药房,2009(1):10-11. |
| |
| 作者姓名： | 武瑞雪 叶露 |
| |
| 作者单位： | 复旦大学公共卫生学院卫生经济教研室,上海市200032 |
| |
| 基金项目： | 国家发改委委托课题“国外专利药品价格管理比较及借鉴研究” |
| |
| 摘 要： | 目的:为我国政府制定和完善专利药价格管理政策提供参考。方法:阐述瑞典专利药价格管理政策,并对其实施效果进行分析,最后根据我国医疗卫生市场情况,总结经验启示。结果与结论:我国政府在对专利药进行定价和价格管理时应当充分利用市场信息,建立专利药品价格信息监控体系,从而减少定价博弈中的信息不对称,确保社会医疗保险资源的高效利用。
|
| 关 键 词： | 专利药 药品价格 价格管理 |
Pricing Policy on Patent Drugs in Sweden and Its Implication for China |
| |
| WU Rui-xue,YE Lu.Pricing Policy on Patent Drugs in Sweden and Its Implication for China[J].China Pharmacy,2009(1):10-11. |
| |
| Authors: | WU Rui-xue YE Lu |
| |
| Institution: | (Dept. of Health Economy, School of Public Health, Fudan University, Shanghai 200032, China) |
| |
| Abstract: | OBJECTIVE： To provide valuable reference for China in formulating and evolving pricing policy on patent drugs. METHODS： The current pricing policy on patent drugs in Sweden and its outcome were analyzed, and then its implication for Chinese medical ＆ health market were summarized. RESULTS ＆ CONCLUSIONS： We suggest that market information should be taken into full consideration and drugs price supervision system should be established in making pricing policy so as to avoid information asymmetry in pricing game and ensure effective utilization of social medical insurance resources. |
| |
| Keywords: | Patent drugs Drugs price Price regulation |
| 本文献已被 维普 等数据库收录！ |
